Clinical Trial Update: Volatile Organic Compounds for the Assessment of Liver Disease

View source ↗

Summary

A completed clinical trial evaluating volatile organic compounds for the assessment of liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma
• Liver Fibrosis

Snippet

Sponsor: Imperial College London | Conditions: Cirrhosis, Cirrhosis, Liver | Status: COMPLETED